Lymphoma Rounds: Chicago
The Crowne Plaza Chicago West Loop (click here for directions)
25 South Halsted Street
Chicago, IL 60661
Wednesday, March 6, 2019
6:30 PM – 9:00 PM
ACTIVITY CHAIR
David Peace, MD
University of Illinois at Chicago
This program is free for healthcare professionals; however, pre-registration is required. Food and refreshments will be provided for all registered participants.
Please note: Only representatives from supporting pharmaceutical companies are invited to register. If your company is interested in becoming a Lymphoma Rounds supporter please contact Piper Harmon, pharmon@lymphoma.org. Exhibit opportunities are also available, however, space is limited.
Companies that have secured a national exhibit sponsorship for Lymphoma Rounds must still rsvp by emailing Piper Harmon (pharmon@lymphoma.org) at least one week before the program to confirm their attendance. Otherwise, an exhibit table will not be guaranteed.
PROGRAM AGENDA
| 6:30 PM | Registration and Dinner Buffet |
|---|---|
| 7:15 PM | Welcome |
| Piper Harmon, Lymphoma Research Foundation | |
| David Peace, MD, University of Illinois at Chicago | |
| 7:25 PM | Pathology: What Is Your Diagnosis? |
| Nicholas Ward, MD, Rush University Medical Center | |
| 7:30 PM | A Sequentially Scrutinized DLBCL Presenting out of Sequence in the Sixth Decade of Life |
| Vijeyaluxmy Motilal Nehru, MD, University of Illinois at Chicago | |
| Pathology | |
| Hongyu Ni, MD, PhD, University of Illinois at Chicago | |
| Shrihari Kadkol, MD, PhD, University of Illinois at Chicago | |
| Moderator | |
| David Peace, MD, University of Illinois at Chicago | |
| 8:00 PM | Extranodal NK/T-Cell Lymphoma (Nasal Type) |
| Brian Johnson, MD, Loyola University Chicago | |
| Pathology | |
| Recep Nigdelioglu, MD, Loyola University Chicago | |
| Moderator | |
| Scott Smith, MD, PhD, FACP, Loyola University Chicago | |
| 8:30 PM | TBA |
| Paul Rubinstein, MD, John H. Stroger, Jr. Hospital | |
| 9:00 PM | Adjourn |
ABOUT THE PROGRAM
The Lymphoma Research Foundation’s Chicago Lymphoma Rounds program provides a forum for healthcare professionals to meet on a regular basis and address issues specific to the diagnosis and treatment of their lymphoma patients. Participants will network, share best practices and learn the latest information on new therapies and advances in the management of lymphoma through interactive case studies presented by lymphoma experts in the Chicago area.
At the conclusion of this educational activity, the participant should be better able to:
- Summarize the latest developments in lymphoma diagnosis, treatment and management.
- Apply best practices for treating lymphoma patients.
- Inform patients about potential clinical trial opportunities.
- Establish a network of health care professionals who work with lymphoma patients.
- Wednesday, May 8, 2019
Chicago Lymphoma Rounds Steering Committee
Loyola University Chicago
Scott Smith, MD, PhD, FACP
Patrick Stiff, MD
Northwestern University
Leo Gordon, MD
Reem Karmali, MD, MS (Chair)
Jane Winter, MD
Rush University Medical Center
Jerome Loew, MD
Sunita Nathan, MD
Parameswaran Venugopal, MD
The University of Chicago
Sonali Smith, MD
Girish Venkataraman, MD
University of Illinois at Chicago
Frederick Behm, MD
David Peace, MD
Joint Providership Statement
This activity has been planned and implemented in accordance with the Accreditation Requirements and Policies of the Accreditation Council for Continuing Medical Education through the joint providership of the University of Nebraska Medical Center, Center for Continuing Education and the Lymphoma Research Foundation.
Accreditation Statement
The University of Nebraska Medical Center, Center for Continuing Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Credit Statement
The University of Nebraska Medical Center, Center for Continuing Education designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credit (s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Sponsors
Lymphoma Research Foundation and the University of Nebraska Medical Center, Center for Continuing Education
This activity is supported by educational grants from:
AbbVie Inc., Celgene Corporation, Genentech, Novartis, Pharmacyclics LLC, an AbbVie Company and Janssen Biotech, Inc., Seattle Genetics, Inc., TG Therapeutics, Inc. and Verastem Oncology
